Newsroom

A team of researchers has developed a modified version of two-photon imaging that can scan deeper within tissue and perform the imaging much faster than previously possible.

– The National Institutes of Health are helping to fund an evolution in medical imaging, and a University at Buffalo-led research team is leading the way.
Jun Xia, PhD, associate professor in the Department of Biomedical Engineering, received a $1.6 million grant to improve medical imaging for people with chronic leg ulcers. The project is a collaboration with the surgery clinic of UBMD Physician’s Group and other UB researchers.

Rapid antigens testing is just as effective in preventing COVID-19 outbreaks as polymerase chain reaction, or PCR, tests when used as part of a regular screening program, according to the National Institutes of Health. Source: McKnight's Long-Term Care News

A small study funded by the US National Institutes of Health (NIS) has found that Covid-19 lateral flow tests (LFTs) can be as effective in detecting SARS-CoV-2 infection as polymerase chain reaction (PCR) tests when used for serial screening conducted every three days. Source: Medical Device Network.

A small study funded by NIH has found that COVID-19 antigen testing and PCR tests are equally effective in detecting SARS-CoV-2 infection when used for serial screening conducted every three days. The results are good news for antigen test makers such as Abbott, Becton Dickinson and Quidel. Source: Medtechdive

Amid the continued deluge of emergency use authorizations from the FDA, rapid antigen tests for COVID-19 are more widely available and easily accessible than ever. Source: FierceBiotech

The editors of MIT Technology Review introduce this year's 35 brilliant young entrepreneurs, inventors, visionaries, humanitarians and pioneers who are working to make the world a better place. Source: MIT Technology Review

In a study that compares rapid antigen and laboratory PCR approaches for COVID-19 serial screening, researchers affiliated with the NIH RADx initiative reported results from 43 people infected with the virus.

In a new study, researchers have designed a miniaturized 3D-printed device to inactivate Pseudomonas aeruginosa, a common bacterium that causes the infection.